Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
Join us at the Oxford Town Hall for the second of our 500th Anniversary lectures, entitled Preparation and Pandemics: Confronting New Threats, from Dame Sarah Gilbert, Professor of Vaccinology at the University of Oxford and Senior Associate Research Fellow at Christ Church on Wednesday 25 June. Professor Dame Sarah Gilbert will examine the power of university-industry collaborations in the battle to beat Nipah Virus, infectious diseases, and pandemic preparedness. This will be followed by a panel discussion with Professor Sir Peter Horby FMedSci FRS, Director, Pandemic Sciences Institute and Moh Family Foundation Professor of Emerging Infectious Diseases and Global Health, University of Oxford and Zakiul Hassan, DPhil Student in Clinical Medicine.
The timings for the event are as follows:
5.30-6.00pm - Doors open for registration
6.00-6.15pm - Welcome and introduction from Hugh Pym (1978, PPE), BBC Health Editor
6.15-7.30pm - Lecture delivered by Dame Sarah Gilbert with panel discussion
7.30-8.00pm - Q&A
8.15-9.30pm - Drinks Reception at Christ Church
Further details for the alumni drinks reception taking place at Christ Church will be announced at a later date. If you select a live stream ticket, the live stream link will be emailed to you before the event.
Please note that unfortunately, parking will not be available at Christ Church. We encourage guests to use one of the Park & Rides or the Westgate Carpark.
Sarah Gilbert is a Professor of Vaccinology in the Pandemic Sciences Institute at the University of Oxford. She works on vaccine technology development, and viral vectored vaccine development, with projects on influenza, Nipah, MERS, and Lassa. Working with colleagues on the Old Road Campus in Oxford, she is able to take novel vaccines from design through GMP manufacturing to clinical development, with a particular interest in the rapid transfer of vaccines into GMP manufacturing and first in human trials. She was the Oxford Project Leader for ChAdOx1 nCoV-19, also known as Vaxevria/Covishield, which was estimated to have saved 6.3 million lives in its first year of use.
Professor Sir Peter Horby FMedSci FRS is Director, Pandemic Sciences Institute and Moh Family Foundation Professor of Emerging Infectious Diseases and Global Health, University of Oxford. Over the last 20 years Peter has led research on a wide range of emerging and epidemic infections, including SARS, avian influenza, Ebola, Lassa fever, plague and COVID-19. He is Director of the Pandemic Sciences Institute, an interdisciplinary research institute at the University of Oxford with a mission to discover, create and enable practical, science-driven solutions to infectious disease threats worldwide. Peter is a regular advisor to the UK Government and the World Health Organization.
Dr Zakiul Hassan is designing a clinical development plan for Nipah virus therapeutics under the supervision of Professor Piero Olliaro and Professor Sir Peter Horby. He is a University of Oxford Clarendon scholar and the first Oxford-MoH Foundation DPhil Scholar. The Reuben Foundation and the NDM studentship also fund his DPhil.
If you have any enquiries, please contact Development Office by emailing development.office@chch.ox.ac.uk.
